Inflammatory and chloracne-like skin lesions in B6C3F1 mice exposed to 3,3',4,4'-tetrachloroazobenzene for 2 years.
Exposure to dioxin and dioxin-like compounds (DLCs) has been connected to the induction of chloracne in humans and animals. 3,3',4,4'-Tetrachloroazobenzene (TCAB) is an environmental contaminant that induces chloracne in humans. TCAB has been studied only to a limited extent in laboratory animals. While performing a 2-year gavage study in B6C3F1 mice to evaluate the toxic and carcinogenic effects of TCAB, we also explored potential chloracnegenic properties. Groups of 50 male and 50 female B6C3F1 mice were exposed by gavage to TCAB at dose levels of 0, 3, 10 and 30 mg/kg for 5 days a week for 2 years. The animals developed treatment-related gross inflammatory skin lesions, which were characterized histologically by inflammation, fibrosis, hyperplasia, and ulcers. Additionally, many of the animals developed follicular dilatation and sebaceous gland atrophy, consistent with chloracne-like lesions. This current 2-year study supports recently published papers showing susceptibility to chloracne in mouse strains other than hairless mice. The chloracne-like lesions were not clinically evident; therefore, our study highlights the need for careful examination of the skin in order to identify subtle lesions consistent with chloracne-like changes in rodents exposed to dioxin and DLCs. Since previous short-term studies did not demonstrate any skin lesions, we suggest that reliable assessment of all safety issues involving dioxin and DLCs requires evaluation following chronic exposure. Such studies in animal models will help to elucidate the mechanisms of dioxin-related health hazards.
Ramot
Yuval
Y
Hadassah - Hebrew University Medical Center, Jerusalem 91200, Israel.
Nyska
Abraham
A
Lieuallen
Warren
W
Maly
Alex
A
Flake
Gordon
G
Kissling
Grace E
GE
Brix
Amy
A
Malarkey
David E
DE
Hooth
Michelle J
MJ
D000818:Animals; D001391:Azo Compounds / Q000633:toxicity*; D054506:Chloracne / Q000473:pathology*; D002722:Chlorobenzenes / Q000633:toxicity*; D003877:Dermatitis, Contact / Q000473:pathology*; D005260:Female; D007441:Intubation, Gastrointestinal; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D012727:Sex Characteristics; D012867:Skin / Q000473:pathology*; D016019:Survival Analysis
D001391:Azo Compounds; D002722:Chlorobenzenes; C013279:3,4,3',4'-tetrachloroazobenzene